Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells

Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cellsHeat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells, Published online: 24 May 2018; doi:10.1038/s41419-018-0691-xHeat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells

http://feeds.nature.com/~r/cddis/rss/current/~3/N2fW2e0usVw/s41419-018-0691-x

Source: Cell death and disease - May 24, 2018 Category: Internal Medicine Authors: Alisha Yallowitz Amr Ghaleb Lucas Garcia Evguenia M. Alexandrova Natalia Marchenko Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Internal Medicine